{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:13:06Z","timestamp":1754482386864},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"FIRB","award":["U12GPFIRB11"],"award-info":[{"award-number":["U12GPFIRB11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0751-9","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T13:13:43Z","timestamp":1516886023000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control"],"prefix":"10.1186","volume":"18","author":[{"given":"Rita","family":"Moretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Dal Ben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gazzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Tiribelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"751_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet Lond Engl. 2012;379:348\u201360.","journal-title":"Lancet Lond Engl"},{"key":"751_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57:775\u201388.","journal-title":"Am J Med"},{"key":"751_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/ard.60.3.290","volume":"60","author":"O Lidove","year":"2001","unstructured":"Lidove O, Cacoub P, Maisonobe T, Servan J, Thibault V, Piette JC, et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis. 2001;60:290\u20132.","journal-title":"Ann Rheum Dis"},{"key":"751_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","volume":"80","author":"O Trejo","year":"2001","unstructured":"Trejo O, Ramos-Casals M, Garc\u00eda-Carrasco M, Yag\u00fce J, Jim\u00e9nez S, de la Red G, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001;80:252\u201362.","journal-title":"Medicine (Baltimore)"},{"key":"751_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","volume":"74","author":"R Nemni","year":"2003","unstructured":"Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74:1267\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"751_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard.57.1.3","volume":"57","author":"M Trendelenburg","year":"1998","unstructured":"Trendelenburg M, Schifferli JA. Cryoglobulins are not essential. Ann Rheum Dis. 1998;57:3\u20135.","journal-title":"Ann Rheum Dis"},{"key":"751_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","volume":"69","author":"PD Gorevic","year":"1980","unstructured":"Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med. 1980;69:287\u2013308.","journal-title":"Am J Med"},{"issue":"2","key":"751_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0022-510X(93)90105-8","volume":"118","author":"B Bonetti","year":"1993","unstructured":"Bonetti B, Monaco S, Giannini C, Ferrari S, Zanusso GL, Rizzuto N. Human peripheral nerve macrophages in normal and pathological conditions. J Neurol Sci. 1993;118(2):158\u201368.","journal-title":"J Neurol Sci"},{"key":"751_CR9","first-page":"305","volume":"21","author":"D Sansonno","year":"1995","unstructured":"Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatol Baltim Md. 1995;21:305\u201312.","journal-title":"Hepatol Baltim Md"},{"key":"751_CR10","first-page":"137","volume":"21","author":"R Moretti","year":"2006","unstructured":"Moretti R, Torre P, Antonello RM, Cattaruzza T, Pizzolato G. Peripheral neuropathy in hepatitis C virus-related mixed cryoglobulinaemia: existing treatments and a positive symptomatic response to oxcarbazepine. Funct Neurol. 2006;21:137\u201340.","journal-title":"Funct Neurol"},{"key":"751_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/WNL.53.4.861","volume":"53","author":"JI Tembl","year":"1999","unstructured":"Tembl JI, Ferrer JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ. Neurologic complications associated with hepatitis C virus infection. Neurology. 1999;53:861\u20134.","journal-title":"Neurology"},{"key":"751_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s004150050388","volume":"246","author":"JG Heckmann","year":"1999","unstructured":"Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neund\u00f6rfer B. Neurological manifestations of chronic hepatitis C. J Neurol. 1999;246:486\u201391.","journal-title":"J Neurol"},{"key":"751_CR13","doi-asserted-by":"publisher","first-page":"236148","DOI":"10.1155\/2012\/236148","volume":"2012","author":"S Monaco","year":"2012","unstructured":"Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S. HCV-related nervous system disorders. Clin Dev Immunol. 2012;2012:236148.","journal-title":"Clin Dev Immunol"},{"key":"751_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3748\/wjg.v18.i2.188","volume":"18","author":"RJ Carvalho-Filho","year":"2012","unstructured":"Carvalho-Filho RJ, Narciso-Schiavon JL, Tolentino LHL, Schiavon LL, Ferraz MLG, AEB S. Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis C. World J Gastroenterol. 2012;18:188\u201391.","journal-title":"World J Gastroenterol"},{"key":"751_CR15","first-page":"391","volume":"30","author":"S Zaltron","year":"1998","unstructured":"Zaltron S, Puoti M, Liberini P, Antonini L, Quinzanini M, Manni M, et al. High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital J Gastroenterol Hepatol. 1998;30:391\u20135.","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"1","key":"751_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.10260","volume":"27","author":"L De Martino","year":"2003","unstructured":"De Martino L, Sampaolo S, Tucci C, et al. Viral RNA in nerve tissue of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve. 2003;27(1):102\u20134.","journal-title":"Muscle Nerve"},{"issue":"2","key":"751_CR17","first-page":"195","volume":"1","author":"LK Younis","year":"2007","unstructured":"Younis LK, Talaat FM, Deif AH, Borei MF, Abdel Reheim SM, El Salmawy DH. Immunohistochemical detection of HCV in nerves and muscles of patients with HCV associated peripheral neuropathy and Myositis. Int J Health Sci (Qassim). 2007;1(2):195\u2013202.","journal-title":"Int J Health Sci (Qassim)"},{"key":"751_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1089-3261(05)70205-1","volume":"5","author":"S Mehta","year":"2001","unstructured":"Mehta S, Levey JM, Bonkovsky HL. Extrahepatic manifestations of infection with hepatitis C virus. Clin Liver Dis. 2001;5:979\u20131008.","journal-title":"Clin Liver Dis"},{"key":"751_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0248-8663(01)00452-0","volume":"22","author":"O Lidove","year":"2001","unstructured":"Lidove O, Maisonobe T, Servan J, Thibault V, L\u00e9ger JM, Piette JC, et al. Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia. Rev M\u00e9d Interne. 2001;22:939\u201347.","journal-title":"Rev M\u00e9d Interne"},{"key":"751_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s004280050380","volume":"434","author":"B Bonetti","year":"1999","unstructured":"Bonetti B, Scardoni M, Monaco S, Rizzuto N, Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch Int J Pathol. 1999;434:533\u20135.","journal-title":"Virchows Arch Int J Pathol"},{"key":"751_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jnnp.60.6.661","volume":"60","author":"E Apartis","year":"1996","unstructured":"Apartis E, L\u00e9ger JM, Musset L, Gugenheim M, Cacoub P, Lyon-Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry. 1996;60:661\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"751_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1529-8027.2002.02007.x","volume":"7","author":"F Gemignani","year":"2002","unstructured":"Gemignani F, Melli G, Inglese C, Marbini A. Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients. J Peripher Nerv Syst JPNS. 2002;7:59\u201364.","journal-title":"J Peripher Nerv Syst JPNS"},{"issue":"4","key":"751_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/CND.0b013e3181b701c1","volume":"11","author":"RL Chin","year":"2010","unstructured":"Chin RL, Sander HW, Brannagna TH, De Sousa E, Latov N. Demyelinating neuropathy in patients with hepatitis C virus infection. J Clin Neuromuscular Disease. 2010;11(4):209\u201312.","journal-title":"J Clin Neuromuscular Disease"},{"issue":"1","key":"751_CR24","first-page":"50","volume":"17","author":"S Vishal","year":"2016","unstructured":"Vishal S, Yoihenba K, Biplab Singh N, Ningshen R, Bhimo Singh T. Demyelinating neuropathy- a rare presentation of HCV infection without mixed cryoglobulinaemia. JIACM. 2016;17(1):50\u20133.","journal-title":"JIACM"},{"key":"751_CR25","doi-asserted-by":"publisher","first-page":"14075","DOI":"10.3390\/ijms160614075","volume":"16","author":"P Conca","year":"2015","unstructured":"Conca P, Caffaro G, de Renzo A, Coppola A, Cimino E, Tarantino G. Successful and safe long-term standard anti-viral therapy in a patient with explosive immune response in course of HCV-related liver cirrhosis. Int J Mol Sci. 2015;16:14075\u201385. \n                    https:\/\/doi.org\/10.3300\/ijms160614075\n                    \n                  .","journal-title":"Int J Mol Sci"},{"issue":"1","key":"751_CR26","first-page":"71","volume":"14","author":"A Carvalho","year":"2013","unstructured":"Carvalho A, Santos Garcia JB, de Sousa Furtado I. Peripheral neuropathy associated to cryoglobulinemia in patients with hepatitis C. Case report and literature review. Rev. Dor Sao Paulo. 2013;14(1):71\u20135.","journal-title":"Dor Sao Paulo"},{"issue":"6","key":"751_CR27","first-page":"1164","volume":"32","author":"JW Levine","year":"2005","unstructured":"Levine JW, Gota C, Fesslerb J, Calabrese LH. Peristent cryoglobulinemic vasculitis following successful treatment of hepatitis virus. The J Rheumatol. 2005;32(6):1164\u20137.","journal-title":"The J Rheumatol"},{"key":"751_CR28","first-page":"1641","volume":"23","author":"L La Civita","year":"1996","unstructured":"La Civita L, Zignego AL, Lombardini F, Monti M, Longombardo G, Pasero G, et al. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Rheumatol. 1996;23:1641\u20133.","journal-title":"J Rheumatol"},{"key":"751_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mus.10118","volume":"25","author":"K Boonyapisit","year":"2022","unstructured":"Boonyapisit K, Katirji B. Severe exacerbation of hepatits C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2022;25:909\u201313.","journal-title":"Muscle Nerve"},{"issue":"Suppl 13","key":"751_CR30","first-page":"S201","volume":"13","author":"M Ballar\u00e8","year":"1995","unstructured":"Ballar\u00e8 M, Bobbio F, Poggi S, Bordin G, Bertoncelli MC, Catania E, et al. A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. Clin Exp Rheumatol. 1995;13(Suppl 13):S201\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"751_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1525-1594.1995.tb02337.x","volume":"19","author":"H Murai","year":"1995","unstructured":"Murai H, Inaba S, Kira J, Yamamoto A, Ohno M, Goto I. Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange. Artif Organs. 1995;19:334\u20138.","journal-title":"Artif Organs"},{"issue":"9","key":"751_CR32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/gut.2005.076646","volume":"55","author":"MP Manns","year":"2006","unstructured":"Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut. 2006;55(9):1350\u20139.","journal-title":"Gut"},{"key":"751_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/jhep.2003.50031","volume":"37","author":"M Schaefer","year":"2003","unstructured":"Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, et al. Adherence and mental side effects during hepatitis C treatment with Interferon alfa and ribavirin in psychiatric risk groups. Hepatology. 2003;37:443\u201351.","journal-title":"Hepatology"},{"key":"751_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack R. The short form McGill pain questionnaire. Pain. 1987;30:191\u20137.","journal-title":"Pain"},{"key":"751_CR35","first-page":"2466","volume":"28","author":"M Naarendorp","year":"2001","unstructured":"Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol. 2001;28:2466\u201373.","journal-title":"J Rheumatol"},{"key":"751_CR36","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46:3317\u201326.","journal-title":"Arthritis Rheum"},{"key":"751_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.20958","volume":"52","author":"P Cacoub","year":"2005","unstructured":"Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette J-C. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005;52:911\u20135.","journal-title":"Arthritis Rheum"},{"key":"751_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/WCO.0b013e32832fbc52","volume":"22","author":"K Toyooka","year":"2009","unstructured":"Toyooka K, Fujimura H. Iatrogenic neuropathies. Curr Opin Neurol. 2009;22:475\u20139.","journal-title":"Curr Opin Neurol"},{"key":"751_CR39","first-page":"631","volume":"22","author":"P Cacoub","year":"1998","unstructured":"Cacoub P, Sba\u00ef A, Hausfater P, Papo T, Gatel A, Piette JC. Central nervous system involvement in hepatitis C virus infection. Gastroent\u00e9rol Clin Biol. 1998;22:631\u20133.","journal-title":"Gastroent\u00e9rol Clin Biol"},{"key":"751_CR40","first-page":"2273","volume":"26","author":"TM Dawson","year":"1999","unstructured":"Dawson TM, Starkebaum G. Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol. 1999;26:2273\u20136.","journal-title":"J Rheumatol"},{"key":"751_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/sj.ki.5000142","volume":"69","author":"N Kamar","year":"2006","unstructured":"Kamar N, Rostaing L, Alric L. Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int. 2006;69:436\u20139.","journal-title":"Kidney Int"},{"issue":"10","key":"751_CR42","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","volume":"75","author":"D Saadoun","year":"2016","unstructured":"Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, Izzedine H, Plaisier A, Fontaine H, Costopoulos M, Le Garff-Tavernier M, Hezode C, Pol S, Musset L, Poynard T, Cacoub P. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2016;75(10):1777\u201382. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-208339\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"751_CR43","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.neuropharm.2005.01.013","volume":"48","author":"HE Shannon","year":"2005","unstructured":"Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology. 2005;48:1012\u201320.","journal-title":"Neuropharmacology"},{"key":"751_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jpainsymman.2004.10.003","volume":"28","author":"S Criscuolo","year":"2004","unstructured":"Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine (Trileptal) monotherapy dramatically improves quality of life in two patients with postherpetic neuralgia refractory to carbamazepine and gabapentin. J Pain Symptom Manag. 2004;28:535\u20136.","journal-title":"J Pain Symptom Manag"},{"key":"751_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-0404.2005.00300.x","volume":"111","author":"S Criscuolo","year":"2005","unstructured":"Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand. 2005;111:229\u201332.","journal-title":"Acta Neurol Scand"},{"key":"751_CR46","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/01.WNL.0000147325.05222.75","volume":"63","author":"G Luef","year":"2004","unstructured":"Luef G, Poewe W. Oxcarbazepine in glossopharyngeal neuralgia: clinical response and effect on serum lipids. Neurology. 2004;63:2447\u20138.","journal-title":"Neurology"},{"issue":"5","key":"751_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hep.1840010511","volume":"1","author":"RG Knodell","year":"1981","unstructured":"Knodell RG, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatits. Hepatology. 1981;1(5):431\u20135.","journal-title":"Hepatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:24:49Z","timestamp":1548375889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0751-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"12 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Guidelines of the Cattinara Hospital Etic Committee. The patients gave their written informed consent to participate to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients gave their written informed consent to publish the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"19"}}